Face to Face with BioVoice News: Harish Bisam, Founder & MD, Bisam Pharmaceuticals

In an exclusive interview, Rahul Koul, Chief Editor, BioVoice News spoke to Harish Bisam, Founder & Managing Director, Bisam Pharmaceuticals who shared insights on his company’s trademark, Quick Vitals, the world's first AI and deep learning powered health monitoring app. He spoke about how it is set to revolutionize health data management and monitoring and much more.
Key talk points:
♦ Tell us briefly about Bisam Pharmaceuticals and how has the company evolved since its inception?
♦ You have recently introduced an App, Quick Vitals, claimed to be the world's first AI & Deep Learning Powered Health Monitoring App. What makes it different from similar Apps in terms of technology and its unique features?
♦ How accurate are the results and whether we can rely on these for the medical diagnosis?
♦ Is this App already available in the market, your subscribers and long term objectives/plans?
♦ You may share a few real user cases where the patients/doctors have really benefited or appreciated the App? What about patient data safety?
♦ I also want to understand if there is regulatory compliance or certifications for such Apps? If yes, how would you ensure compliance while fostering innovation?
♦ What is your approach to understanding and addressing the topmost patient requirements in the digital health space?
♦ How do you look at the future of health-tech evolving in India, particularly with innovations in AI, IoT, and digital diagnostics?
Quick Vitals is an innovative platform designed to deliver real time insights and actionable data, empowering individuals and healthcare providers to make informed decisions. The app aims to enhance patient outcomes and streamline health monitoring processes, making healthcare more accessible and efficient.
Website: quickvitals.ai/
Download link: onelink.to/rjsshb